Clinical Trials
10 trialsNCT00545766 2021-12-16
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
SCRI Development Innovations, LLC
Phase 2 Completed
NCT02057913 2020-07-23
VinCaP
Institute of Cancer Research, United Kingdom
Phase 2 Completed
NCT02665039 2019-10-08
VINGEM
Karolinska University Hospital
Phase 2 Completed
NCT01844947 2019-04-26
VINSOR
Karolinska University Hospital
Phase 1 Completed
NCT01529411 2019-04-04
MAJA
Spanish Oncology Genito-Urinary Group
Phase 2 Completed
NCT00284180 2013-08-09
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00284154 2013-03-13
Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01265940 2012-10-10
Pazopanib and Vinflunine in Urothelial Cancer of the Bladder
Lukas-Krankenhaus GmbH
Phase 1/2 Completed
NCT00320073 2012-05-16
Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT00251446 2012-05-11
A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer
Veeda Oncology
Phase 2 Completed